Iterum Therapeutics Plc (ITRMF)

0.055 +0.01 (+29.72%) USD  |  OTCM  |  May 06, 16:00
More

Iterum Therapeutics SG&A Expense (TTM) : 15.57M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for ITRMF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Amarin Corp. Plc 92.35M
Jazz Pharmaceuticals Plc 1.295B
Prothena Corp. Plc 59.39M
GH Research Plc 21.95M
Cosmo Pharmaceuticals NV 30.19M